Cingulate Inc. Warrants
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials. It also develops CTx-2103 (buspirone) that is in a formulation stage for th… Read more
Cingulate Inc. Warrants (CINGW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -1.222x
Based on the latest financial reports, Cingulate Inc. Warrants (CINGW) has a cash flow conversion efficiency ratio of -1.222x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.24 Million) by net assets ($3.47 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cingulate Inc. Warrants - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Cingulate Inc. Warrants's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cingulate Inc. Warrants Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cingulate Inc. Warrants ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
New Momentum Corporation
PINK:NNAX
|
0.018x |
|
Grapefruit USA Inc
PINK:GPFT
|
0.001x |
|
Chapters Group AG
XETRA:CHG
|
0.040x |
|
Polymeric Resources Corporation
PINK:PLYR
|
N/A |
|
Lanbay Inc
PINK:LNBY
|
-0.312x |
|
Syros Pharmaceuticals Inc
NASDAQ:SYRS
|
1.860x |
|
Fila Korea Ltd.
KQ:081660
|
N/A |
|
2G ENERGY - Dusseldorf Stock Exchang
DU:2GB
|
N/A |
Annual Cash Flow Conversion Efficiency for Cingulate Inc. Warrants (2019–2024)
The table below shows the annual cash flow conversion efficiency of Cingulate Inc. Warrants from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $7.46 Million | $-18.45 Million | -2.475x | -213.08% |
| 2023-12-31 | $-6.87 Million | $-15.03 Million | 2.189x | +153.49% |
| 2022-12-31 | $3.88 Million | $-15.88 Million | -4.091x | -717.41% |
| 2021-12-31 | $20.84 Million | $-10.43 Million | -0.501x | +90.50% |
| 2020-12-31 | $1.29 Million | $-6.81 Million | -5.270x | +65.95% |
| 2019-12-31 | $615.88K | $-9.53 Million | -15.478x | -- |